CD19 and breast cancer: Similar to our previous studies, both a higher percentage and absolute number of CD19+CD24+CD38+ B cells were found in the CD19+ B cells cultured with PD-L1hi BC cells than in the CD19+ B cells cultured with PD-L1lo BC cells or control cells under DR conditions (P < 0.05 for all; Figure 5B).